Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy

This publication has 15 references indexed in Scilit:

• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
  New England Journal of Medicine, 2003
• Local-Regional Breast Cancer Recurrence: Prognostic Groups Based on Patterns of Failure
  The Breast Journal, 2002
• Treatment of established osteoporosis: a systematic review and cost-utility analysis
  Health Technology Assessment, 2002
• Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer
  PharmacoEconomics, 2002
• Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
  Journal of Clinical Oncology, 2001
• Health-related Quality of Life in Economic Evaluations for Osteoporosis
  Medical Decision Making, 1999
• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer
  Breast Cancer Research and Treatment, 1997
• Markov Models in Medical Decision Making
  Medical Decision Making, 1993
• The significance of local recurrence of carcinoma of the breast
  International Journal of Radiation Oncology*Biology*Physics, 1983